Rockefeller University is a well-funded research institution on the verge of expansion, with a new two-story, 160,000 square foot laboratory building priced at $240 million in the works, a new $25 million research fund established for new techniques in drug discovery and a recent NIH grant for researchers studying vaccine response totaling $2.4 million.
Science Market Update
Among Rockefeller University’s new life science funding is a $2.4 million grant from the NIH that will be used to fund a study involving integrating innate and adaptive pathways in vaccine response. The funding organization within the NIH that awarded this life science grant is the National Institute of Allergy and Infectious Diseases, and the project start date was April 1st, 2014.
A new laboratory building is officially in the works at Rockefeller University after being approved by the New York City Council last month. The two-story, 160,000 square foot building over the FDR Drive will accommodate about 26 labs and 440 scientists. Priced at $240 million, the new lab space will feature a landscaped green roof with two glass pavilions, one for offices and a second to house a cafeteria.
A new $25 million research fund has been established at Rockefeller University to aid in new techniques for drug discovery. The Robertson Therapeutic Development Fund was created in light of a generous $25 million gift from the Robertson Foundation, established by investment manager Julian H. Robertson, Jr. and his family.
Are you interested in reaching the $1.5 Billion New York laboratory sales and service marketplace?
Researchers from Rockefeller University and Necker Medical School in Paris worked together to discover one way fungal infections spread below the skin’s surface on a genetic level. The condition, known as dermatophytosis, can mean that an infection spreads to the lymph nodes, bones, digestive tract or the brain. The team of researchers discovered a genetic deficiency that makes this possible, shedding light on the theory that says genetic deficiencies can cause normally healthy people to become very ill from an infection.
Reading our Science Market Update blog is a great way to stay informed of industry trends and research, funding and life science building news, but did you know that there is also a great deal of funding and life science market news available on our company news blog? We have put together a list, including links to the articles, of some recent news posted on our Life Science Company and Industry News Briefs blog available to life science sales and marketing professionals interested in staying informed of life science marketing and industry news.
Tags: 2014, University of California Los Angeles, Harvard University, Rockefeller University, University of Arizona, University of Pittsburgh, Pennsylvania, Northeast, University of Pennsylvania, UPenn, New York, UPITT, Southwest, California, Los Angeles, Alabama, University of Alabama, Southern, Massachusetts, Life Science Company and Industry News Briefs, Arizona, Boston, LAVS, Philadelphia, UAZ, RockU, BioResearch Product Faire Event, UAlab, Harvard, Birmingham, Front Line, Tucson, Pittsburgh, Stony Brook, industry news, funding news, Science Market Update, Science Researcher Update, NIH grants, life science events, SunySB
Science researchers at Rockefeller University, Duke University and the University of California, San Francisco recently conducted a study that found that the pain and red skin associated with sunburn is caused by a molecule that’s heavily concentrated in the skin’s epidermis. The study was published in the Proceedings of the National Academy of Sciences. The results of this study could lead to a way to prevent sunburn and possibly other sources of pain.
Researchers at Rockefeller University, led by Brian Chait, have been awarded a $2.3 million grant by the NIH for the National Resource for the Mass Spectrometric Analysis of Biological Macromolecules. According to the Rockefeller University website, the National Resource for the Mass Spectrometric Analysis of Biological Macromolecules is now in its 39th year of receiving funding from the NIH. The abstract on the NIH RePORTER says of the project:
Science researcher C. David Allis is head of the Laboratory of Chromatin Biology and Epigenetics at Rockefeller University, and he has been awarded a $1 million grant from the Starr Cancer Consortium. As the leader of one of five cancer research teams from New York City based members of the consortium, Allis was one of 27 people to submit a grant application and a member of one of five collaborative cancer research teams selected as a winner. The Starr Cancer Consortium gave out a total of $5 million dollars over two years.